Citation: Tf. Burns et al., Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo, ONCOGENE, 20(34), 2001, pp. 4601-4612
Citation: Tf. Burns et Ws. El-deiry, Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach, J BIOL CHEM, 276(41), 2001, pp. 37879-37886
Authors:
Ozoren, N
Kim, KH
Burns, TF
Dicker, DT
Moscioni, AD
El-Deiry, WS
Citation: N. Ozoren et al., The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand, CANCER RES, 60(22), 2000, pp. 6259-6265
Authors:
Wu, GS
Burns, TF
McDonald, ER
Meng, RD
Kao, G
Muschel, R
Yen, T
El-Deiry, WS
Citation: Gs. Wu et al., Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest, ONCOGENE, 18(47), 1999, pp. 6411-6418
Authors:
Wu, GS
Burns, TF
Zhan, Y
Alnemri, ES
El-Deiry, WS
Citation: Gs. Wu et al., Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor, CANCER RES, 59(12), 1999, pp. 2770-2775